• body weight and body composition did not change after 2 weeks of treatment• treatment with• either low-dose or high-dose r-metHuLeptin did not improve• liver, skeletal muscle, or adipose tissue insulin sensitivity• in weight stable, obese subjects with type 2 diabetes. This evidence concerns the gene INS and type 2 diabetes mellitus.